This inventor holds 5 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Cemm Forschungszentrum Fur Molekulare Medizin Gmbh, Proxygen Gmbh. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 11 
1 out of 1 Years Active: 2018-2026
Title: The Innovative Contributions of Stefan Kubicek
Introduction
Stefan Kubicek is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of molecular medicine, particularly in the development of compounds that target various diseases. With a total of 5 patents to his name, his work focuses on innovative solutions for complex medical challenges.
Latest Patents
One of Kubicek's latest patents involves oxazole and thioazole-type cullin ring ubiquitin ligase compounds. This invention relates to compounds that can stimulate or induce the ubiquitination of target proteins. These compounds have the potential to degrade proteins associated with diseases such as cancer, metabolic disorders, infectious diseases, and neurological disorders. The invention also outlines methods for identifying and testing compounds that can induce ubiquitination, as well as their use as medicaments in pharmaceutical compositions.
Another significant patent by Kubicek is the combination of an antiandrogen with a vitamin K antagonist or a gamma-glutamyl carboxylase inhibitor. This invention aims to treat or prevent androgen receptor-positive cancers, such as prostate cancer. It also provides a method for resensitizing antiandrogen-resistant prostate cancer to treatment, showcasing the potential of his work in advancing cancer therapies.
Career Highlights
Stefan Kubicek has worked with esteemed organizations, including the Center for Molecular Medicine (CEMM). His experience in molecular medicine has allowed him to contribute to groundbreaking research and development in the field.
Collaborations
Throughout his career, Kubicek has collaborated with notable colleagues, including Sara Sdelci and Jin Li. These partnerships have further enriched his research and innovation efforts.
Conclusion
Stefan Kubicek's contributions to molecular medicine through his patents and collaborations highlight his role as a leading inventor in the field. His innovative approaches to treating complex diseases continue to pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile